Most of the common thrombolytic drugs that are used in clinic, such as streptokinase, tissue-type plasminogen activator (tPA), and uPA, are macromolecular compounds, while small molecular compounds have not been used to treat thrombotic diseases [39]. The gene discussed is PLAT; the disease is thrombotic disease.